Lanfix-O Tablet is a combination antibiotic formulation containing Cefixime 200 mg, Ofloxacin 200 mg, and Lactobacillus 60 million spores, designed for the treatment of a broad spectrum of bacterial infections. Cefixime, a third-generation cephalosporin, exerts bactericidal activity by inhibiting bacterial cell wall synthesis, effective against gram-positive and gram-negative pathogens. Ofloxacin, a fluoroquinolone antibiotic, inhibits bacterial DNA gyrase and topoisomerase IV, disrupting DNA replication and transcription, thereby enhancing the antimicrobial spectrum and efficacy. The inclusion of Lactobacillus spores helps maintain and restore normal intestinal flora, minimizing antibiotic-associated diarrhea and dysbiosis during treatment. Lanfix-O is indicated for respiratory tract infections, urinary tract infections, gastrointestinal infections, skin and soft tissue infections, and other susceptible bacterial infections. It is particularly useful in mixed infections where both gram-positive and gram-negative organisms are suspected. Dosage and duration should be determined by a healthcare professional based on infection severity and patient response. Caution is advised in patients with hypersensitivity to cephalosporins or fluoroquinolones, and it should be used judiciously to prevent antibiotic resistance. Common side effects may include gastrointestinal disturbances, headache, and dizziness. Lanfix-O Tablet should be stored in a cool, dry place away from direct sunlight.